Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV et al (2022) 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis 18(12):1345–1356. https://doi.org/10.1016/j.soard.2022.08.013

Article  PubMed  Google Scholar 

Steenackers N, Vanuytsel T, Augustijns P, Tack J, Mertens A, Lannoo M et al (2021) Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass. Lancet Gastroenterol Hepatol 6(3):225–237. https://doi.org/10.1016/S2468-1253(20)30302-2

Article  PubMed  Google Scholar 

Dahan A, Porat D, Azran C, Mualem Y, Sakran N, Abu-Abeid S (2019) Lithium toxicity with severe bradycardia post sleeve gastrectomy: a case report and review of the literature. Obes Surg 29(2):735–738. https://doi.org/10.1007/s11695-018-3597-x

Article  PubMed  Google Scholar 

Lloret-Linares C, Hirt D, Bardin C, Bouillot JL, Oppert JM, Poitou C et al (2014) Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach. Clin Pharmacokinet 53(10):919–930. https://doi.org/10.1007/s40262-014-0163-0

Article  CAS  PubMed  Google Scholar 

Triplett JD, Simpson HD, Clemmons RS, Cascino GD (2021) The effect of weight reduction surgery on the efficacy and tolerability of epilepsy pharmacotherapy. Epilepsy Behav 124:108307. https://doi.org/10.1016/j.yebeh.2021.108307

Article  PubMed  Google Scholar 

Busetto L, Dicker D, Azran C, Batterham RL, Farpour-Lambert N, Fried M et al (2018) Obesity management task force of the European association for the study of obesity released “practical recommendations for the post-bariatric surgery medical management.” Obes Surg 28(7):2117–2121. https://doi.org/10.1007/s11695-018-3283-z

Article  PubMed  Google Scholar 

Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L (2021) Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg 31(5):1937–1948. https://doi.org/10.1007/s11695-020-05207-7

Article  PubMed  PubMed Central  Google Scholar 

Carlsson LMS, Sjöholm K, Jacobson P, Andersson-Assarsson JC, Svensson PA, Taube M et al (2020) Life expectancy after bariatric surgery in the Swedish obese subjects study. N Engl J Med 383(16):1535–1543. https://doi.org/10.1056/NEJMoa2002449

Article  PubMed  PubMed Central  Google Scholar 

van Kinschot CM, van Erp NP, Feberwee T, Dezentjé VO (2015) Sunitinib treatment in a patient with metastatic renal cell carcinoma and bariatric surgery. Eur J Clin Pharmacol 71(10):1279–1281. https://doi.org/10.1007/s00228-015-1902-3

Article  PubMed  Google Scholar 

Wills SM, Zekman R, Bestul D, Kuwajerwala N, Decker D (2010) Tamoxifen malabsorption after Roux-en-Y gastric bypass surgery: case series and review of the literature. Pharmacotherapy 30(2):217. https://doi.org/10.1592/phco.30.2.217

Article  PubMed  Google Scholar 

Herbrink M, Nuijen B, Schellens JH, Beijnen JH (2015) Variability in bioavailability of small molecular tyrosine kinase inhibitors. Cancer Treat Rev 41(5):412–422. https://doi.org/10.1016/j.ctrv.2015.03.005

Article  CAS  PubMed  Google Scholar 

Guideline IH: Biopharmaceutics classification system-based biowaivers M9. https://database.ich.org/sites/default/files/M9_Guideline_Step4_2019_1116.pdf (2019). Accessed 18 October 2023.

Buckley ST, Frank KJ, Fricker G, Brandl M (2013) Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations.” Eur J Pharm Sci 50(1):8–16. https://doi.org/10.1016/j.ejps.2013.04.002

Article  CAS  PubMed  Google Scholar 

Sawicki E, Schellens JH, Beijnen JH, Nuijen B (2016) Inventory of oral anticancer agents: pharmaceutical formulation aspects with focus on the solid dispersion technique. Cancer Treat Rev 50:247–263. https://doi.org/10.1016/j.ctrv.2016.09.012

Article  CAS  PubMed  Google Scholar 

Veerman GDM, Hussaarts KGAM, Jansman FGA, Koolen SWL, van Leeuwen RWF, Mathijssen RHJ (2020) Clinical implications of food-drug interactions with small-molecule kinase inhibitors. Lancet Oncol 21(5):e265–e279. https://doi.org/10.1016/S1470-2045(20)30069-3

Article  CAS  PubMed  Google Scholar 

Porat D, Vaynshtein J, Gibori R, Avramoff O, Shaked G, Dukhno O et al (2021) Stomach pH before vs. after different bariatric surgery procedures: clinical implications for drug delivery. Eur J Pharmaceut Biopharmaceut 160:152–157. https://doi.org/10.1016/j.ejpb.2021.01.016

Article  CAS  Google Scholar 

Jaruvongvanich V, Matar R, Ravi K, Murad MH, Vantanasiri K, Wongjarupong N et al (2020) Esophageal pathophysiologic changes and adenocarcinoma after bariatric surgery: a systematic review and meta-analysis. Clin Transl Gastroenterol 11(8):e00225. https://doi.org/10.14309/ctg.0000000000000225

Article  PubMed  PubMed Central  Google Scholar 

Groenland SL, van Nuland M, Verheijen RB, Schellens JHM, Beijnen JH, Huitema ADR et al (2019) Therapeutic drug monitoring of oral anti-hormonal drugs in oncology. Clin Pharmacokinet 58(3):299–308. https://doi.org/10.1007/s40262-018-0683-0

Article  CAS  PubMed  Google Scholar 

van der Kleij MBA, Guchelaar NAD, Mathijssen RHJ, Versluis J, Huitema ADR, Koolen SLW et al (2023) Therapeutic drug monitoring of kinase inhibitors in oncology. Clin Pharmacokinet. https://doi.org/10.1007/s40262-023-01293-9

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Chia YL, Nedelman J, Schran H, Mahon FX, Molimard M (2009) A therapeutic drug monitoring algorithm for refining the imatinib trough level obtained at different sampling times. Ther Drug Monit 31(5):579–584. https://doi.org/10.1097/FTD.0b013e3181b2c8cf

Article  CAS  PubMed  Google Scholar 

Groenland SL, van Eerden RAG, Verheijen RB, de Vries N, Thijssen B, Rosing H et al (2020) Cost-neutral optimization of pazopanib exposure by splitting intake moments: a prospective pharmacokinetic study in cancer patients. Clin Pharmacokinet 59(7):941–948. https://doi.org/10.1007/s40262-020-00863-5

Article  CAS  PubMed  Google Scholar 

Nienhuijs SW, Bruinsma FFE. Dutch Audit for the Treatment of Obesity (DATO) Jaarverslag 2022. https://dica.nl/media/3189/DATO%20jaarverslag%202022.pdf (2023). Accessed 18 Jan 2024.

Park DM, Shah DD, Egorin MJ, Beumer JH (2009) Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgery. J Neurooncol 93(2):279–283. https://doi.org/10.1007/s11060-008-9773-4

Article  PubMed  Google Scholar 

Verheijen RB, Bins S, Mathijssen RH, Lolkema MP, van Doorn L, Schellens JH et al (2016) Individualized Pazopanib dosing: a prospective feasibility study in cancer patients. Clin Cancer Res 22(23):5738–5746. https://doi.org/10.1158/1078-0432.CCR-16-1255

Article  CAS  PubMed  Google Scholar 

Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M et al (2024) Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection. Cancer Chemother Pharmacol 93(2):169–175. https://doi.org/10.1007/s00280-023-04574-z

Article  CAS  PubMed  Google Scholar 

Marty M, Fumoleau P, Adenis A, Rousseau Y, Merrouche Y, Robinet G et al (2001) Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors. Ann Oncol 12(11):1643–1649. https://doi.org/10.1023/a:1013180903805

Article  CAS  PubMed  Google Scholar 

Kingma JS, Burgers DMT, Monpellier VM, Wiezer MJ, Blussé van Oud-Alblas HJ, Vaughns JD et al (2021) Oral drug dosing following bariatric surgery: general concepts and specific dosing advice. Br J Clin Pharmacol 87(12):4560–4576. https://doi.org/10.1111/bcp.14913

Article  CAS  PubMed  Google Scholar 

Lau C, van Kesteren C, Smeenk R, Huitema A, Knibbe CAJ (2023) Impact of bariatric surgery in the short and long term: a need for time-dependent dosing of drugs. Obes Surg 33(10):3266–3302. https://doi.org/10.1007/s11695-023-06770-5

Article  PubMed  PubMed Central  Google Scholar 

Griggs JJ, Bohlke K, Balaban EP, Dignam JJ, Hall ET, Harvey RD et al (2021) Appropriate systemic therapy dosing for obese adult patients with cancer: ASCO guideline update. J Clin Oncol 39(18):2037–2048. https://doi.org/10.1200/JCO.21.00471

Article  PubMed  Google Scholar 

Madlensky L, Natarajan L, Tchu S, Pu M, Mortimer J, Flatt SW et al (2011) Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes. Clin Pharmacol Ther 89(5):718–725. https://doi.org/10.1038/clpt.2011.32

Article  CAS  PubMed  Google Scholar 

Sternberg CN, Donskov F, Haas NB, Doehn C, Russo P, Elmeliegy M et al (2018) Pazopanib exposure relationship with clinical efficacy and safety in the adjuvant treatment of advanced renal cell carcinoma. Clin Cancer Res 24(13):3005–3013. https://doi.org/10.1158/1078-0432.CCR-17-2652

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leenhardt F, Fiteni F, Gauthier L, Alexandre M, Guiu S, Firmin N et al (2022) Pharmacokinetic variability drives palbociclib-induced neutropenia in metastatic breast cancer patients: drug-drug interactions are the usual suspects. Pharmaceutics 14(4):841. https://doi.org/10.3390/pharmaceutics14040841

Article  CAS  PubMed  PubMed Central  Google Scholar 

Desta Z, Kreutz Y, Nguyen AT, Li L, Skaar T, Kamdem LK et al (2011) Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age. Clin Pharmacol Ther 90(5):693–700. https://doi.org/10.1038/clpt.2011.174

Article  CAS  PubMed  Google Scholar 

Mohmaed Ali MI, Bruin MAC, Dezentjé VO, Beijnen JH, Steeghs N, Huitema ADR (2023) Exposure-response analyses of olaparib in real-life patients with ovarian cancer. Pharm Res 40(5):1239–1247. https://doi.org/10.1007/s11095-023-03497-x